TABLE 2.
PNA array | Identification by:
|
|
---|---|---|
Sequencing | Specific PCR | |
6 (15) | 6 (15) | -c |
11 (5) | 11 (5) | - |
16 (6) | 16 (6) | - |
18 (5) | 18 (5) | - |
31 (1) | 31 (1) | - |
35 (1) | 35 (1) | - |
53 (5) | 53 (5) | - |
61 (0)b | 61 (1) | - |
62 (1) | 62 (1) | - |
66 (3) | 66 (3) | - |
70 (2) | 70 (2) | - |
81 (3) | 81 (3) | - |
83 (1) | 83 (1) | - |
84 (0)b | 84 (1) | - |
11,45d | 11 | 11,45 |
53,70d | 53 | 53,70 |
53,56d | 53 | 53,56 |
18,44d | 18 | 18,44 |
53,35d | 53 | 53,35 |
62,58d | 62 | 62,58 |
31,53d | 31 | 31,53 |
6,39d | 6 | 6,39 |
53,66,70d | 66 | 53,66,70 |
16,53 | 16,53 | - |
16,53,54d | 16,53 | 16,53,54 |
We used three approaches to identify the clinical samples. The numbers are HPV types. The numbers in parentheses are the numbers of the types detected. Total, 72; negative, 12; positive, 60.
Probes for HPV types 61 and 84 were not included in the PNA array.
Type-specific PCR was not performed in cases where PNA array results and sequencing results were in good agreement.
These 10 case of multiple infections were confirmed to have mixed infection on analysis by type-specific PCR and sequencing.